Key facts
- This page summarizes Christopher E. Kevane's Form 4 filing for UNIVERSAL TECHNICAL INSTITUTE INC (UTI).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Dec 2025, 20:15.
Christopher E. Kevane - 10 Dec 2025 Form 4 Insider Report for UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
- Reporting relationship
- EVP and Chief Legal Officer
- Issuer ticker
- UTI
- Reported as of
- 10 Dec 2025
- Net transaction value
- -$410,525
- SEC form
- 4
- Accepted by SEC
- 12 Dec 2025, 20:15:39 UTC
- Prior SEC filing
- 10 Dec 2025
- Next SEC filing
- 19 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Kevane
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher E. Kevane filed Form 4 for UNIVERSAL TECHNICAL INSTITUTE INC (UTI) on 12 Dec 2025.
Change
- Previous filing in this sequence was filed on 10 Dec 2025.
- Current net transaction value: -$410,525.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001486632
Primary reporting owner
Kevane Christopher E.
- Relationship
- EVP and Chief Legal Officer
- Address
- 4225 E. WINDROSE DRIVE, SUITE 200, PHOENIX
- Signature
- /s/ Christopher Kevane
- Signature date
- 12 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
UTI
transaction
Common Stock, $0.0001 par value
Award
- Transaction value
- Shares
- +13,012
- Change %
- +12%
- Price
- Shares after
- 125,567
- Date
- 10 Dec 2025
- Ownership
- Direct
- Footnotes
- F1, F2
UTI
transaction
Common Stock, $0.0001 par value
Tax liability
- Transaction value
- $265,827
- Shares
- -10,828
- Change %
- -8.6%
- Price
- $24.55
- Shares after
- 114,739
- Date
- 11 Dec 2025
- Ownership
- Direct
- Footnotes
- F3
UTI
transaction
Common Stock, $0.0001 par value
Tax liability
- Transaction value
- $82,292
- Shares
- -3,352
- Change %
- -2.9%
- Price
- $24.55
- Shares after
- 111,387
- Date
- 11 Dec 2025
- Ownership
- Direct
- Footnotes
- F4
UTI
transaction
Common Stock, $0.0001 par value
Tax liability
- Transaction value
- $62,406
- Shares
- -2,542
- Change %
- -2.3%
- Price
- $24.55
- Shares after
- 108,845
- Date
- 11 Dec 2025
- Ownership
- Direct
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The restricted stock units ("RSU") vest in three equal installments beginning on December 15, 2026.
Footnote F2
Each RSU represents a contingent right to receive one share of issuer's Common Stock.
Footnote F3
Shares withheld by the issuer to satisfy tax-withholding obligations upon settlement of the performance-based restricted stock units granted on December 8, 2022.
Footnote F4
Shares withheld by the issuer to satisfy tax-withholding obligations upon vesting of restricted stock units granted on December 8, 2022.
Footnote F5
Shares withheld by the issuer to satisfy tax-withholding obligations upon vesting of restricted stock units granted on December 8, 2023.